AXTA— AI Stock Forecast & Price Targets
Published 8/4/2026 · A free sample of K3vl4r’s AI-powered analysis.
Kronos price forecasts, scored fundamentals & technicals, and a multi-horizon plan.
View the live AXTA price forecast →
Axalta's recent earnings show modest sales growth but softer margins and declining net income, while its merger with AkzoNobel offers structural upside. Technicals indicate resistance near $36.50 with forecast bands suggesting limited near-term upside, though forward valuation metrics remain attractive at 12.7x P/E.
Hold near $36.28; invalidation below $30.00, target $36.50 for short-term momentum play
Accumulate if merger closes by Q1 2027; expect upside on accretive synergies and improved margins; catalysts include regulatory approval and integration progress
Long-term value in a merged entity with global scale, but secular risks from industrial slowdowns could limit growth to low single digits
Revenue grew modestly to $1.346B in Q2 2026 (+3.1% YoY), but net income fell to $89M (-18.4% YoY) with gross margins at 34.0%, operating margins at 15.2%, and net margins at 6.7%. The balance sheet remains weak with debt-to-equity of 119.4x, though free cash flow is healthy at $539.5M. Forward P/E of 12.7x suggests valuation is attractive relative to peers, but high leverage and declining net margins raise concerns about near-term stability.
The chart shows a strong uptrend with recent resistance at $36.50 (actual price), while the Kronos AI forecast band indicates potential for a pullback to $32.365-32.894. The 52-week high of $36.82 is now below current price, and RSI at 65.91 suggests overbought conditions. Short interest (4.4%) is low but rising, with technical support near $30.00.
Recent earnings show sales growth but declining net income due to margin compression, while the merger with AkzoNobel remains a key catalyst. Analysts raised price targets to $39 (BMO) and $37 (Baird), but the company's high debt load and integration risks are significant concerns. The forecast band suggests limited upside beyond current levels.
- Merger with AkzoNobel expected to create a global coatings leader by 2027, driving revenue synergies of $1.5B annually
- High debt load (D/E > 119x) requiring significant restructuring
- Integration risks from AkzoNobel merger timeline uncertainty
- Margin compression due to competitive pressures in specialty chemicals
Get AI analysis on any stock
This is one of hundreds of Kronos AI reports — scored fundamentals & technicals, bull/base/bear price targets, a multi-horizon plan, and continuously-updated forecasts across the market. Create a free account to explore them all.
Create your free account →Already a member? Sign in · Join our Discord